智通财经网·2026-01-26 23:45Group 1 - The U.S. government proposed to maintain the payment rates for Medicare Advantage plans at current levels for next year, disappointing investors and causing significant stock declines for major insurance companies [1][2] - Major insurers such as UnitedHealth, CVS Health, and Humana experienced stock drops of 9.3%, 10%, and over 15% respectively following the announcement [1] - The Centers for Medicare & Medicaid Services (CMS) indicated that the payment rate increase for Medicare Advantage plans is expected to be only 0.09% by 2027, far below analysts' expectations of a 6% increase [1][2] Group 2 - The proposed payment rates imply minimal growth for Medicare Advantage insurers, who are already facing profit pressures due to rising medical costs and government funding shortfalls [1][2] - The total payment increase for Medicare Advantage plans in 2027 is projected to be only $700 million, a negligible amount compared to the typical multi-billion dollar growth in the industry [2] - CMS is working on additional policies aimed at improving payment accuracy, ensuring beneficiary choice, and providing reasonably priced insurance coverage for Medicare beneficiaries [2] Group 3 - The Medicare Payment Advisory Commission estimates that by 2025, the government costs for covering individuals through Medicare Advantage plans will increase by 20%, approximately $84 billion [3] - Insurance companies argue that the government payment levels have not kept pace with rising costs, leading to operational challenges in the Medicare Advantage business [3] - Analysts from TD Cowen previously predicted a payment rate increase of 5% to 6% for 2027, warning that a rate increase below 4% could significantly pressure insurance company stock prices [3]